| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.0082 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |